Edward J. Septimus, M.D., FACP, FIDSA, FSHEA

Medical Director, Infection Prevention and Epidemiology Clinical Services Group, HCA Healthcare System

Professor of Internal Medicine, Texas A&M Health Science Center College of Medicine

Edward J. Septimus, M.D., FACP, FIDSA, FSHEA, is Medical Director, Infection Prevention and Epidemiology at Hospital Corporation of America (HCA) and Professor of Internal Medicine at Texas A&M Health Science Center College of Medicine in Houston, Texas. He is also Professor and Distinguished Senior Fellow at the George Mason University School of Public Health. His practice interests include patient safety, infection prevention, antimicrobial stewardship and resistance, public health including vaccine preventable diseases, sepsis, medical informatics, clinical integration, and human factors engineering. Dr. Septimus has lectured nationally and internationally on surviving sepsis, reduction of healthcare-associated infections, antimicrobial stewardship, influenza, methicillin-resistant Staphylococcus aureus (MRSA), the economic case for quality, and employee health. He is Past President of the Texas Infectious Diseases Society and has served on the Board of Directors of the IDSA. He is on the IDSA Antimicrobial Resistance Committee, the SHEA Antimicrobial Stewardship Committee, and the IDSA Quality Measurement Committee. In 2011 he was appointed to the Healthcare-Associated Infections/Preventable Adverse Events Advisory Panel for the Texas Department of State Health Services. Dr. Septimus is also a member of the FDA Anti-Infective Drug Advisory Group and is co-chair of the National Quality Forum (NQF) Patient Safety Steering Committee.

Bryan R. Cobb, PhD, FACMG

Program Partner Lead, Roche Diagnostics Information Solutions, Roche Diagnostics Information Solutions

Bryan Cobb is the Partner Lead for the GE Healthcare - Roche partnership program in Acute Care. With GE Healthcare’s in vivo patient monitoring and Roche’s in vitro diagnostics expertise, the team is developing novel digital CDS tools, AI-derived cognitive agents, and predictive analytics that aim to help clinicians identify patient deterioration sooner while improving cognitive burden, patient outcomes, but most importantly, save lives. 
Dr. Cobb obtained a Ph.D. in Medical Genetics at the University of Alabama at Birmingham and completed an American Board of Medical Genetics post-doctoral fellowship at NIH (National Human Genome Research Institute). He is a board-certified diplomat of the American College of Medical Genetics & Genomics.  
He has held several roles at Roche, including Head of Medical Affairs for RMS, Director for RDC’s Molecular Centers of Excellence, and has over 15 years of experience in diagnostics.  He has published in key scientific journals, is a scientific reviewer for journals such as the Journal of Clinical Microbiology, and has served on several international scientific committees and working groups.